Small interfering RNA–mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema
Author(s) -
Nicolai Ε. Savaskan,
Alexandra Heckel,
Eric Hahnen,
Tobias Engelhorn,
Arnd Doerfler,
Oliver Ganslandt,
Christopher Nimsky,
Michael Buchfelder,
Ilker Y. Eyüpoglu
Publication year - 2008
Publication title -
nature medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.536
H-Index - 547
eISSN - 1546-170X
pISSN - 1078-8956
DOI - 10.1038/nm1772
Subject(s) - neurodegeneration , gene silencing , small interfering rna , glioma , glutamate receptor , edema , neuroscience , programmed cell death , brain edema , biology , medicine , pathology , cancer research , rna , apoptosis , gene , biochemistry , receptor , disease
Neurodegeneration and brain edema are hallmarks of human malignant brain tumors. Here we show that genetic or pharmacological inhibition of the glutamate transporter xCT (X(c-) system, encoded by SLC7a11) in vivo leads to abrogated neurodegeneration, attenuated perifocal edema and prolonged survival. These results show a crucial role for xCT in glioma-induced neurodegeneration and brain edema, corroborating the concept that edema formation may be in part a consequence of peritumoral cell death.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom